Hypoxia-inducible factor-1 alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients
IntroductionThe detection of peripheral blood circulating tumor cells (CTCs) and bone marrow disseminated tumor cells (DTCs) in breast cancer patients is associated with a high incidence of disease relapse and disease-related death. Since hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) play an important role in angiogenesis and tumor progression, the purpose of the current study was to investigate their expression in CTCs.
Methods: The expression of cytokeratins (CK), VEGF, vascular endothelial growth factor receptor-2 (VEGFR2), HIF-1 alpha and phosphorylated-focal adhesion kinase (pFAK) in CTCs from 34 patients with metastatic breast cancer who had detectable CK-19 mRNA-positive CTCs was assessed using double staining experiments and confocal laser scanning microscopy.
Peripheral blood mononuclear cells (PBMCs) were stained with a monoclonal A45-B/B3 pancytokeratin antibody in combination with either VEGF or VEGFR2 or HIF-1 alpha or pFAK antibodies, respectively.
Results: pFAK expression in CTCs was detected in 92% of patients whereas expression of VEGF, VEGFR2 and HIF-1 alpha was observed in 62%, 47% and 76% of patients, respectively. VEGF, VEGFR2, HIF-1 alpha and pFAK were expressed in 73%, 71%, 56% and 81%, respectively, of all the detected CTCs.
VEGF mRNA was also detected by quantitative real-time RT-PCR in immunomagnetically-separated CTCs. Double and triple staining experiments in cytospins of immunomagnetically-isolated CTCs showed that VEGF co-expressed with HIF-1 alpha and VEGFR2.
Conclusions: The expression of pFAK, HIF-1 alpha, VEGF and VEGFR2 in CTCs of patients with metastatic breast cancer could explain the metastatic potential of these cells and may provide a therapeutic target for their elimination.
Author: Galatea KallergiHarris MarkomanolakiVicky GiannoukarakiMaria PapadakiAreti StratiEvi LianidouVassilis GeorgouliasDimitris MavroudisSophia Agelaki
Credits/Source: Breast Cancer Research 2009, 11:R84
Published on: 2009-11-17
Copyright by the authors listed above - made available via BioMedCentral (Open Access). Please
make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. If you wish submit your own press release, click here.
Social Bookmarking
RETWEET This! | Digg this! | Post to del.icio.us | Post to Furl | Add to Netscape | Add to Yahoo! | Rojo
|
|
